#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12704	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2077	599.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1412	1412	C	689	C,T	663,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23144	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3597	634.5	0	.	n	.	0	T695C	SNP	695	695	T	1038	1038	C	712	C,T	685,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23144	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3597	634.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1680	1680	A	713	A,G	673,24	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23144	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3597	634.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2314	2314	C	667	C	643	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23144	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3597	634.5	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2940	2940	T	706	T,C	661,19	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23144	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3597	634.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2388	2388	A	699	A	678	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1506	folP	852	852	100.0	folP.l6.c4.ctg.1	1477	100.1	1	SNP	p	R228S	1	.	.	682	684	AGC	967	969	AGC	145;144;146	A;G;C	142;141;139	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3730	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3513	104.5	1	SNP	p	S91F	0	.	.	271	273	TCC	650	652	TCC	134;134;134	T;C,T;C	131;129,4;133	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3730	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3513	104.5	1	SNP	p	D95N	0	.	.	283	285	GAC	662	664	GAC	127;125;125	G;A,G;C	125;118,3;122	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	3730	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3513	104.5	1	SNP	p	D95G	0	.	.	283	285	GAC	662	664	GAC	127;125;125	G;A,G;C	125;118,3;122	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1212	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1311	91.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	413	415	ACC	131;133;130	A,G;C;C	125,3;131;128	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1212	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1311	91.2	0	.	p	.	0	R44H	NONSYN	130	132	CGC	428	430	CAC	128;129;132	C;A,G;C	127;122,3;131	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1212	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1311	91.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	611	613	CAC	144;142;143	C,T;A;C	137,5;136;140	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1212	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1311	91.2	1	SNP	p	G45D	0	.	.	133	135	GGC	431	433	GGC	135;137;138	G;G;C	132;132;135	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	692	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	995	68.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2872	130.3	1	SNP	p	D86N	0	.	.	256	258	GAC	538	540	GAC	148;146;149	G;A;C	146;140;143	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2872	130.3	1	SNP	p	S87W	0	.	.	259	261	AGT	541	543	AGT	151;151;152	A,C;G;T	146,3;149;150	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2872	130.3	1	SNP	p	S87R	0	.	.	259	261	AGT	541	543	AGT	151;151;152	A,C;G;T	146,3;149;150	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2872	130.3	1	SNP	p	S87I	0	.	.	259	261	AGT	541	543	AGT	151;151;152	A,C;G;T	146,3;149;150	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3800	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2872	130.3	1	SNP	p	S88P	0	.	.	262	264	TCC	544	546	TCC	152;150;149	T;C;C	148;145;146	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3092	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2570	118.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1537	1539	GGC	179;180;179	G;G;C	175;176;170	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3016	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2210	132.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1152	1154	GCA	172;172;173	G;C,A;A,C	164;166,1;165,4	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3016	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2210	132.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1155	1157	ATC	177;178;177	A;T;C,G	170;168;165,4	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3016	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2210	132.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1167	1169	GTG	170;169;169	G,A;T,C;G,C	163,4;161,4;162,4	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3016	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2210	132.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1167	1169	GTG	170;169;169	G,A;T,C;G,C	163,4;161,4;162,4	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3016	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2210	132.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1671	1673	ACC	134;131;131	A;C;C	127;130;130	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3016	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2210	132.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1725	1727	GCG	129;127;128	G;C,G;G	124;114,1;122	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3016	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2210	132.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1725	1727	GCG	129;127;128	G;C,G;G	124;114,1;122	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3016	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2210	132.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1848	1850	GGC	108;105;104	G;G;C,T	104;102;101,2	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3016	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2210	132.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1857	1859	GGC	99;99;98	G,A;G;C	93,2;97;93	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3016	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2210	132.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1875	1877	CCG	79;78;77	C;C,G;G	73;71,1;67	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	4606	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3175	142.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1743	1745	CTG	169;168;171	C;T,C;G	164;154,3;163	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1694	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1899	87.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	502	502	C	115	C	109	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2378	porB1b	1035	1035	95.82	porB1b.l15.c30.ctg.1	1394	166.9	0	.	p	.	0	E48G	NONSYN	142	144	GAA	341	343	GGA	195;194;201	G,A;G;A	188,1;190;193	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2378	porB1b	1035	1035	95.82	porB1b.l15.c30.ctg.1	1394	166.9	0	.	p	.	0	F135L	NONSYN	403	405	TTT	602	604	CTT	198;200;200	C,G;T;T,G	191,4;198;194,4	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2378	porB1b	1035	1035	95.82	porB1b.l15.c30.ctg.1	1394	166.9	0	.	p	.	0	R143G	NONSYN	427	429	AGA	626	628	GGA	203;204;204	G,C;G,A;A	197,3;198,3;199	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2378	porB1b	1035	1035	95.82	porB1b.l15.c30.ctg.1	1394	166.9	0	.	p	.	0	D171G	NONSYN	511	513	GAT	710	712	GGT	192;192;193	G;G,A;T,C	181;182,1;171,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2378	porB1b	1035	1035	95.82	porB1b.l15.c30.ctg.1	1394	166.9	0	.	p	.	0	G189S	NONSYN	565	567	GGC	764	766	AGC	197;197;196	A;G,A;C	195;188,5;193	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2378	porB1b	1035	1035	95.82	porB1b.l15.c30.ctg.1	1394	166.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	830	830	T	177	T	168	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2378	porB1b	1035	1035	95.82	porB1b.l15.c30.ctg.1	1394	166.9	1	SNP	p	G120K	0	.	.	358	360	GGT	557	559	GGT	199;200;199	G,A;G,A;T,G	190,4;190,4;182,6	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2378	porB1b	1035	1035	95.82	porB1b.l15.c30.ctg.1	1394	166.9	1	SNP	p	A121N	0	.	.	361	363	GCC	560	562	GCC	200;196;196	G,A;C,A;C	192,4;189,4;193	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2378	porB1b	1035	1035	95.82	porB1b.l15.c30.ctg.1	1394	166.9	1	SNP	p	A121D	0	.	.	361	363	GCC	560	562	GCC	200;196;196	G,A;C,A;C	192,4;189,4;193	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8886	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	4820	181.0	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1912	1914	AAT	176;173;173	A,C;A;T	169,3;168;168	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	986	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	943	102.2	1	SNP	p	V57M	1	.	.	169	171	ATG	465	467	ATG	184;187;186	A;T;G	175;177;177	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
